Gabelli Healthcare & WellnessRX Trust to Redeem Its Outstanding 5.875% Series B Cumulative Preferred Shares
RYE, N.Y.--(BUSINESS WIRE)--The Board of Trustees of The Gabelli Healthcare & WellnessRX Trust (NYSE:GRX) (the “Fund”) authorized the redemption of all outstanding
From and after the Redemption Date, the Series B Preferred Shares being redeemed will no longer be deemed outstanding, dividends will cease to accumulate and all the rights of the holders of the Series B Preferred Shares with respect to the Series B Preferred Shares will cease, except the right to receive the Redemption Price, without interest.
All of the Series B Preferred Shares are held in book-entry form through the Depository Trust Company ("DTC") and shares will be redeemed in accordance with the procedures of DTC. Payment to DTC for the Series B Preferred Shares will be made by Computershare Trust Company, N.A., as paying agent for this redemption.
The Series B Preferred Shares, which trade on the New York Stock Exchange under the symbol “GRX Pr B”, are rated “A2” by Moody’s Investors Service and have an annual dividend rate of
Questions relating to, and requests for additional copies of, the notice of redemption and the related materials should be directed to the Fund at 800-GABELLI (800-422-3554) or (914) 921-5070.
About The Gabelli Healthcare & WellnessRX Trust
The Gabelli Healthcare & WellnessRX Trust is a diversified, closed-end management investment company with
NYSE – GRX Pr B
CUSIP – 36246K301
Contacts
Investor Relations Contact:
Bethany Uhlein
(914) 921-5546
buhlein@gabelli.com